Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).

Authors

R Patarca
A Isava
R Campo
N J. Rodriguez
E Nunez
M Alter
M Marchette
M M. Sanabia
Christopher Mitchell, Nova Southeastern UniversityFollow
D Rivera
G Scott
D Jayaweera
J Moreno
C Boulanger

Document Type

Article

ISSN

0731-8898

Publication Date

1-1-2003

Volume

22

Issue

4

First Page

235

Last Page

79

Disciplines

Medicine and Health Sciences

NSUWorks Citation

Patarca, R; Isava, A; Campo, R; Rodriguez, N J.; Nunez, E; Alter, M; Marchette, M; Sanabia, M M.; Mitchell, Christopher; Rivera, D; Scott, G; Jayaweera, D; Moreno, J; and Boulanger, C, "Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2)." (2003). Department of Health Sciences Faculty Articles. 126.
https://nsuworks.nova.edu/hpd_hs_facarticles/126